Skip to main content

Table 2 Comparison of basic data among three subgroups

From: Symptom and functional networks of patients with cancer in different latent risk subgroups based on patient-reported outcomes

Variable

Value

Group

F/\(\:{x}^{2}\)

P

High-risk (n = 196)

Low-risk

(n = 716)

Medium-risk

(n = 492)

Age

 

58.53\(\:\pm\:\)13.15

55.62\(\:\pm\:\)14.20

57.83\(\:\pm\:\)12.29

5.838

0.003

Sex

Male

107 (12.6%)

444 (52.2%)

299 (35.2%)

3.295

0.192

 

Female

89 (15.9%)

272 (49.3%)

193 (34.8%)

  

Height(cm)

 

165.74\(\:\pm\:\)7.62

166.83\(\:\pm\:\)7.91

165.64\(\:\pm\:\)7.79

3.782

0.023

Weight(kg)

 

59.99\(\:\pm\:\)11.48

63.66\(\:\pm\:\)11.27

61.21\(\:\pm\:\)11.18

11.489

< 0.001

Blood type

A

30 (16.1%)

97 (52.2%)

59 (31.7%)

12.548

0.250

 

B

43 (16.2%)

145 (54.7%)

77 (29.1%)

  
 

AB

16 (16.3%)

49 (50.0%)

33 (33.7%)

  
 

O

38 (14.4%)

138 (52.5%)

87 (33.1%)

  
 

No known

67 (11.7%)

284 (49.3%)

224 (39.0%)

  

Level of education

Primary school and below

58 (16.9%)

157 (45.8%)

128 (37.3%)

14.484

0.025

 

Middle school

86 (15.3%)

282 (50.2%)

194 (34.5%)

  
 

High school

36 (11.3%)

176 (55.2%)

107 (33.5%)

  
 

Bachelor and above

14 (8.4%)

99 (59.3%)

54 (32.3%)

  

Marital status

Unmarried

8 (14.3%)

36 (64.3%)

12 (21.4%)

11.937

0.154

 

Married

173 (13.9%)

642 (51.5%)

432 (34.6%)

  
 

Divorced

2 (14.3%)

4 (28.6%)

8 (57.1%)

  
 

Widowed

12 (15.8%)

33 (43.4%)

31 (40.8%)

  

Average monthly income

Low

134 (15.0%)

426 (47.7%)

333 (37.3%)

13.181

0.010

 

Middle

60 (12.3%)

283 (57.9%)

146 (29.9%)

  
 

High

1 (11.1%)

5 (55.6%)

3 (33.3%)

  

Medical insurance

Self funded

7 (11.1%)

34 (54.0%)

22 (34.9%)

0.466

0.792

 

Non self funded

187 (14.0%)

681 (51.2%)

463 (34.8%)

  

Occupation

peasant

117 (14.9%)

369 (46.9%)

300 (38.2%)

27.734

0.006

 

worker

43 (16.0%)

150 (56.0%)

75 (28.0%)

  
 

Institution

6 (20.0%)

13 (43.3%)

11 (36.7%)

  
 

Other

29 (9.4%)

183 (59.0%)

98 (31.6%)

  

Family history

No

161 (13.3%)

645 (53.2%)

407 (33.6%)

10.301

0.036

 

Yes

32 (21.5%)

66 (44.3%)

51 (34.2%)

  

Allergy history

No

169 (13.4%)

657 (52.2%)

432 (34.3%)

8.145

0.017

 

Yes

24 (22.6%)

55 (51.9%)

27 (25.5%)

  

Smoking

No

116 (15.4%)

394 (52.3%)

245 (32.4%)

6.318

0.388

 

Smoking

28 (14.7%)

97 (50.8%)

66 (34.6%)

  
 

Given up smoking

45 (11.3%)

208 (52.4%)

144 (36.3%)

  

Drink

No

129 (15.8%)

417 (51.2%)

269 (33.0%)

10.028

0.123

 

Occasionally drinking

21 (10.8%)

112 (57.4%)

62 (31.8%)

  
 

Regularly drinking

10 (17.9%)

24 (42.9%)

22 (39.3%)

  
 

Given up drinking

29 (10.5%)

146 (52.9%)

101 (36.6%)

  

Comorbidity

No

38 (33.9%)

42 (37.5%)

32 (28.6%)

41.023

< 0.001

 

Yes

157 (12.2%)

674 (52.2%)

461 (35.6%)

  

Cancer staging

I

9 (11.8%)

35 (46.1%)

32 (42.1%)

39.764

< 0.001

 

II

44 (16.4%)

94 (34.9%)

131 (48.7%)

  
 

III

59 (9.2%)

392 (60.9%)

193 (30.0%)

  
 

IV

81 (20.4%)

191 (48.0%)

126 (31.6%)

  

Metastasis

No

118 (11.6%)

569 (56.2%)

326 (32.2%)

24.222

< 0.001

 

Yes

57 (21.2%)

112 (41.6%)

100 (37.2%)

  

Disease systems

Respiratory system

40 (11.6%)

180 (52.2%)

125 (36.2%)

11.649

0.168

 

Digestive system

93 (16.4%)

252 (44.5%)

221 (39.0%)

  
 

Hematological system

27 (13.0%)

115 (55.3%)

66 (31.7%)

  
 

Endocrine system

19 (12.2%)

63 (48.1%)

52 (39.7%)

  
 

other

16 (12.2%)

63 (48.1%)

52 (39.7%)

  

Primary treatment modality

Surgery

103 (14.7%)

388 (55.3%)

210 (30.0%)

48.582

< 0.001

chemotherapy

55 (17.8%)

127 (41.1%)

127 (41.1%)

  
 

Radiotherapy

132 (15.0%)

440 (49.9%)

310 (35.1%)

  
 

Other

11 (11.7%)

25 (26.6%)

58 (61.7%)

 Â